ISSN 2394-5125
 

Research Article 


REGULATORY REQUIREMENTS FOR REGISTRATION OF DRUGS IN BRAZIL

Mr. Vignesh M, Dr. Ganesh Gnk, Ms. Sruthi N.

Abstract
One of the highly regulated industries is the pharmaceutical industries with more rules,
restrictions and regulations accomplished by the government to look after the comfort and prosperity of the
public wellness. In the current scenario regulatory requirements differ from the country to country around the
globe. Registration of drug products in the developing countries is a more challenging task, unlike regulated
countries as they are not unified. Brazilians are requesting better human services and current medications,
introducing huge open doors for outside ventures. In Brazil, restorative item enlistment is a broad procedure.
The economical implication of the developing market is growing universally. The preference given to the
International Council for Harmonisation (ICH) committee which is a precursor for the guidance universally in
the application of preparing drug dossier to integrate the quality, security and competent reporting
configurations. The role of investigators is stringent in dealing with the plant inspections right from the Active
Pharmaceutical Ingredient (API) or Drug Substance (DS) till the finished drug product specifications. The
registration process for the medicines takes over a year. In Latin America, Brazil, Argentina, and Chile are
nations which give consolation to nonexclusive item enrolment by limiting the enlistment charges for generics.
This review discusses about the registration, marketing authorization and regulatory requirements for marketing
the drugs in Brazil.

Key words: ANVISA, Requirements, Key challenges, Registration, Growth plan


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Mr. Vignesh M
Articles by Dr. Ganesh Gnk
Articles by Ms. Sruthi N
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Mr. Vignesh M, Dr. Ganesh Gnk, Ms. Sruthi N. REGULATORY REQUIREMENTS FOR REGISTRATION OF DRUGS IN BRAZIL. JCR. 2020; 7(19): 5290-5295. doi:10.31838/jcr.07.19.615


Web Style

Mr. Vignesh M, Dr. Ganesh Gnk, Ms. Sruthi N. REGULATORY REQUIREMENTS FOR REGISTRATION OF DRUGS IN BRAZIL. http://www.jcreview.com/?mno=133354 [Access: September 14, 2020]. doi:10.31838/jcr.07.19.615


AMA (American Medical Association) Style

Mr. Vignesh M, Dr. Ganesh Gnk, Ms. Sruthi N. REGULATORY REQUIREMENTS FOR REGISTRATION OF DRUGS IN BRAZIL. JCR. 2020; 7(19): 5290-5295. doi:10.31838/jcr.07.19.615



Vancouver/ICMJE Style

Mr. Vignesh M, Dr. Ganesh Gnk, Ms. Sruthi N. REGULATORY REQUIREMENTS FOR REGISTRATION OF DRUGS IN BRAZIL. JCR. (2020), [cited September 14, 2020]; 7(19): 5290-5295. doi:10.31838/jcr.07.19.615



Harvard Style

Mr. Vignesh M, Dr. Ganesh Gnk, Ms. Sruthi N (2020) REGULATORY REQUIREMENTS FOR REGISTRATION OF DRUGS IN BRAZIL. JCR, 7 (19), 5290-5295. doi:10.31838/jcr.07.19.615



Turabian Style

Mr. Vignesh M, Dr. Ganesh Gnk, Ms. Sruthi N. 2020. REGULATORY REQUIREMENTS FOR REGISTRATION OF DRUGS IN BRAZIL. Journal of Critical Reviews, 7 (19), 5290-5295. doi:10.31838/jcr.07.19.615



Chicago Style

Mr. Vignesh M, Dr. Ganesh Gnk, Ms. Sruthi N. "REGULATORY REQUIREMENTS FOR REGISTRATION OF DRUGS IN BRAZIL." Journal of Critical Reviews 7 (2020), 5290-5295. doi:10.31838/jcr.07.19.615



MLA (The Modern Language Association) Style

Mr. Vignesh M, Dr. Ganesh Gnk, Ms. Sruthi N. "REGULATORY REQUIREMENTS FOR REGISTRATION OF DRUGS IN BRAZIL." Journal of Critical Reviews 7.19 (2020), 5290-5295. Print. doi:10.31838/jcr.07.19.615



APA (American Psychological Association) Style

Mr. Vignesh M, Dr. Ganesh Gnk, Ms. Sruthi N (2020) REGULATORY REQUIREMENTS FOR REGISTRATION OF DRUGS IN BRAZIL. Journal of Critical Reviews, 7 (19), 5290-5295. doi:10.31838/jcr.07.19.615